Tian Mingzhen, Ma Zhichao, Yang Guang-Zhong
Institute of Medical Robotics, School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai 200240, China.
Innovation (Camb). 2023 Nov 27;5(1):100548. doi: 10.1016/j.xinn.2023.100548. eCollection 2024 Jan 8.
Drug delivery to the brain is crucial in the treatment for central nervous system disorders. While significant progress has been made in recent years, there are still major challenges in achieving controllable drug delivery to the brain. Unmet clinical needs arise from various factors, including controlled drug transport, handling large drug doses, methods for crossing biological barriers, the use of imaging guidance, and effective models for analyzing drug delivery. Recent advances in micro/nanosystems have shown promise in addressing some of these challenges. These include the utilization of microfluidic platforms to test and validate the drug delivery process in a controlled and biomimetic setting, the development of novel micro/nanocarriers for large drug loads across the blood-brain barrier, and the implementation of micro-intervention systems for delivering drugs through intraparenchymal or peripheral routes. In this article, we present a review of the latest developments in micro/nanosystems for controllable drug delivery to the brain. We also delve into the relevant diseases, biological barriers, and conventional methods. In addition, we discuss future prospects and the development of emerging robotic micro/nanosystems equipped with directed transportation, real-time image guidance, and closed-loop control.
药物递送至大脑对于中枢神经系统疾病的治疗至关重要。尽管近年来已取得显著进展,但在实现可控的药物递送至大脑方面仍存在重大挑战。未满足的临床需求源于多种因素,包括药物的可控运输、处理大剂量药物、跨越生物屏障的方法、成像引导的应用以及分析药物递送的有效模型。微/纳米系统的最新进展在应对其中一些挑战方面显示出了前景。这些进展包括利用微流控平台在可控和仿生环境中测试和验证药物递送过程,开发用于跨越血脑屏障携带大剂量药物的新型微/纳米载体,以及实施通过实质内或外周途径递送药物的微干预系统。在本文中,我们对用于可控药物递送至大脑的微/纳米系统的最新进展进行综述。我们还深入探讨了相关疾病、生物屏障和传统方法。此外,我们讨论了未来前景以及配备定向运输、实时图像引导和闭环控制的新兴机器人微/纳米系统的发展。
Innovation (Camb). 2023-11-27
Pharm Dev Technol. 2023-1
Molecules. 2022-9-9
Pharmaceutics. 2022-2-17
Adv Drug Deliv Rev. 2017-9-15
Pharm Nanotechnol. 2024
J Mater Chem B. 2023-3-8
J Inflamm Res. 2025-6-13
Pharmaceutics. 2025-4-30
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2025
Front Cell Infect Microbiol. 2025-2-11
Biomimetics (Basel). 2025-1-3
Nat Rev Mater. 2022-4
Adv Drug Deliv Rev. 2023-6
J Control Release. 2023-5
Proc Natl Acad Sci U S A. 2023-3-28
Innovation (Camb). 2023-2-16